Securities
Issues & Trends
Noul Co., Ltd. Obtains Class II Medical Device Approval in Canada… "Accelerating Entry into the North American Market"
Noul Co., Ltd.(376930), a company specializing in AI-based blood and cancer diagnostics, announced on the 18th that it has obtained a Class II medical device license from Health Canada for the “Malari…
- 2026-08-18 14:38:04
- Park Jung-Soo
Issues & Trends
LaonPeople Inc. to Resume Trading on the 20th Following a Stock Split… “Full-Scale Profitability Begins”
AI specialist LaonPeople Inc.(300120)has completed a stock consolidation and will resume trading on the 20th. The company plans to pursue growth centered on profitability, building on its return to pr…
- 2026-08-18 14:34:32
- Park Jung-Soo
Issues & Trends
KOSPI Fluctuates Around the 6,900 Mark Amid Institutional Selling… Semiconductor Stocks 'Stall'
The KOSPI, which had risen as much as 3% early in the session, has given up all its gains and continues to trade lower around the 6,900 level in the afternoon. While retail and foreign investors are n…
- 2026-08-18 13:37:04
- Shin Ha-yeon
Issues & Trends
VIVOZON PHARMACEUTICAL Reports 2Q Sales of 2 Billion Won for ‘Anaprazu’… Up 229% from the Previous Quarter
VIVOZON PHARMACEUTICAL(082800)announced on the 18th that sales of its non-narcotic analgesic “Anaprazu” reached approximately 2 billion won in the second quarter of this year, marking a 229% increase …
- 2026-08-18 11:23:12
- Shin Ha-yeon
Issues & Trends
PLANTYNET Co., Ltd. Reports First-Half Revenue of 20 Billion Won… “Expanding Global Digital Care Business”
IT solutions specialist PLANTYNET Co., Ltd.(075130)announced on the 18th that it recorded consolidated revenue of 20.02 billion won, operating profit of 560 million won, and net income of 490 million …
- 2026-08-18 10:30:29
- Shin Ha-yeon
Issues & Trends
SAM CHUN DANG PHARM CO. LTD Reaches Global Settlement with Regeneron and Bayer in Ailera 2mg Patent Dispute
SAM CHUN DANG PHARM CO. LTD(000250)has settled the global patent dispute it had been engaged in with Regeneron and Bayer regarding the Eylea biosimilar “SCD411.”SAM CHUN DANG PHARM CO. LTD announced o…
- 2026-08-18 10:28:55
- Park Jung-Soo
Issues & Trends
MDS Tech Reports First-Ever First-Half Revenue of 100 Billion… “Profitability Exceeds Last Year’s Full-Year Results”
MDS Tech(086960)reported that, driven by revenue growth in artificial intelligence (AI) and embedded solutions as well as improved performance from its subsidiaries, the company surpassed 100 billion …
- 2026-08-18 10:23:11
- Park Jung-Soo
Issues & Trends
B2En Becomes Independent from Ssangbangwool’s Management Structure… New Largest Shareholder: ‘Strategy No. 1’
B2En(307870)announced on the 18th that it will break away from Ssangbul’s existing management structure and establish an independent management system centered on a new majority shareholder.
B2En C…
- 2026-08-18 10:20:52
- Kim Hyung-il
Issues & Trends
KSP CO., LTD Reports Record-High Order Backlog of 115.9 Billion Won in First Half… Up 42% Year-Over-Year
KSP CO., LTD(073010)(KSP) posted its highest-ever order backlog for the first half of the year, driven by an increase in orders for marine engine parts. Second-quarter revenue also exceeded 30 billion…
- 2026-08-18 10:20:25
- Park Jung-Soo
Issues & Trends
TAIHAN Fiberoptics Co.,LTD Turns Operating and Net Profit Positive in 2Q… North America Accounts for 46% of Sales
Daehan Optical Communications ( TAIHAN Fiberoptics Co.,LTD(010170)), a company specializing in optical fibers and optical cables, announced on the 18th that it returned to profitability in operating i…
- 2026-08-18 10:16:47
- Kim Hyung-il
PHARM EDAILY
Shorts